NCT07823322
- Conditions
- CRC (Colorectal Cancer), Colonic Diseases, Colonic Neoplasms, +14 more
- Locations
-
Not specified
Clinical trial condition
Neoplasm, Residual
Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.
207 public trials
79 recruiting studies
Neoplasm, Residual trial results
Not yet recruiting
CM336 Plus Daratumumab and Lenalidomide in Transplant-Ineligible Newly Diagnosed Multiple Myeloma
NCT07830485
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Not yet recruiting
Perioperative Adebrelimab for Locally Advanced Cervical Cancer
NCT07811375
- Conditions
- Disease Attributes, Disease Progression, Locally Advanced Cervical Cancer, +6 more
- Locations
-
- Anhui province hospital Hefei, China
Not yet recruiting
Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
NCT07748689
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified
Not yet recruiting
ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)
NCT07597252
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
- Locations
-
- Linkou Chang Gung Memorial Hospital Taoyuan, Taiwan
NCT07740486
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified
Not yet recruiting
TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)
NCT07720843
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
Not specified
Not yet recruiting
Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients
NCT07709585
- Conditions
- Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 L858R Mutation, +6 more
- Locations
-
- Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
Not yet recruiting
Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
NCT07690891
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Not yet recruiting
Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry
NCT07691034
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified